dual glp 1 and gip receptor agonist examples Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Targeting GLP-1, GIP & GCG
Description
Researchers said this suggested that the underlying diabetes rather than the medication may be the causal factor.
Funding The authors have nothing to report
doi: 10.7759/cureus.77725 70 VoorsAAAngermannCETeerlinkJRCollinsSPKosiborodMBiegusJet al
Compounded medications use the same active ingredients as brand-name versions, prepared by FDA-registered compounding pharmacies following strict quality standards
Accessed September 19, 2018
